Tau and neurofilament light‐chain as fluid biomarkers in spinocerebellar ataxia type 3

Abstract

Our results suggest that tau might be a marker of early disease stages in SCA3. NfL can discriminate mutation carriers from controls and is associated with different clinical variables. Longitudinal studies are required to confirm their potential role as biomarkers in clinical trials.